Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
"Verygrass" appears to be a brand and naming variant associated with Qinghai Spring, a China-based publicly listed company focused on cordyceps sinensis and related health products rather than a standalone biotech developing conventional drug pipelines. The company markets cordyceps-derived products under the Verygrass brand, including pure powder tablets and other traditional Chinese medicine products, and also operates beverage businesses. Its business is centered on commercialization of consumer health and TCM products, not on disclosed clinical-stage therapeutic assets typical of venture biotech or pharma companies. As a result, the best match for the query is Qinghai Spring rather than an independent company named Verygrass.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Verygrass.